发明名称 Ny fremgangsmåte for nedregulering av amyloid
摘要 Disclosed are novel methods for combatting diseases characterized by deposition of amyloid. The methods generally rely on immunization against amyloidogenic proteins (proteins contributing to formation of amyloid) such as beta amyloid (A²). Immunization is preferably effected by administration of analogues of autologous amyloidogenic polypeptides, said analogues being capable of inducing antibody production against the autologous amyloidogenic polypeptides. Especially preferred as an immunogen is autologous A² which has been modified by introduction of one single or a few foreign, immunodominant and promiscuous T-cell epitopes while substantially preserving the majority of A²'s B-cell epitopes. Also disclosed are nucleic acid vaccination against amyloidogenic polypeptides and vaccination using live vaccines as well as methods and means useful for the vaccination. Such methods and means include methods for identification of useful immunogenic analogues of the amyloidogenic proteins, methods for the preparation of analogues and pharmaceutical formulations, as well as nucleic acid fragments, vectors, transformed cells, polypeptides and pharmaceutical formulations.
申请公布号 NO20023961(D0) 申请公布日期 2002.08.20
申请号 NO20020003961 申请日期 2002.08.20
申请人 PHARMEXA A/S 发明人 JENSEN, MARTIN ROLAND;BIRK, PETER;NIELSEN, KLAUS GREGORIUS
分类号 G01N33/53;A61K35/12;A61K35/66;A61K35/76;A61K38/00;A61K38/17;A61K38/18;A61K38/20;A61K39/00;A61K39/385;A61K39/39;A61K48/00;A61P25/28;C07K14/47;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/09;C12P21/02;(IPC1-7):A61K 主分类号 G01N33/53
代理机构 代理人
主权项
地址